Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma

ConclusionMaintaining Ctrough median above 42.68  ng/mL was crucial for achieving the ORR in patients with HCC.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research